Stock VISTAPH6 VISTA PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Vista Pharmaceuticals Limited

Equities

VISTAPH6

INE427C01021

Market Closed - Bombay S.E.
Other stock markets
 06:00:56 2024-06-14 EDT 		5-day change 1st Jan Change
13.9 INR +0.36% Intraday chart for Vista Pharmaceuticals Limited 0.00% -5.25%
05-28 Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
02-10 Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Vista Pharmaceuticals Limited announced that it expects to receive INR 0.533334 million in funding
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Vista Pharmaceuticals Limited Announces the Resignation of Mr. Nishant Talreja from the Post of Company Secretary, Compliance Officer and Key Managerial Personnel
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Vista Pharmaceuticals Limited Announces Change in Corporate Office Address
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Vista Pharmaceuticals Limited announced that it has received INR 61.895 million in funding
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Vista Pharmaceuticals Appoints Chairman
MT
Vista Pharmaceuticals Limited Announces Executive Changes
CI
Vista Pharmaceuticals Limited Approves Resignation of Narendra Gilaka as Independent Director of the Company
CI
Vista Pharmaceuticals Limited announced that it expects to receive INR 66.895 million in funding
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Vista Pharmaceuticals Limited Announces Resignation of Akash Bhagadia as Company Secretary and Compliance Officer
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Vista Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VISTAPH6 Stock
  4. News Vista Pharmaceuticals Limited